February 23, 2026 · Form 4 insider transaction
Yea Christopher sold 4,347 shares of KalVista Pharmaceuticals, Inc. at $15.57 per share, a transaction worth $67.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.5182 to $15.566982 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.